Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab

This study is ongoing, but not recruiting participants.

Study NCT00588900 Information provided by National Cancer Institute (NCI)

First Received: December 20, 2007 Last Updated: February 24, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)